{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:00:36Z","timestamp":1740146436630,"version":"3.37.3"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Research of Novel Broad-spectrum Antibacterial Agent of Tulathromycin Raw Materials and its Preparation","award":["2015B090901059"],"award-info":[{"award-number":["2015B090901059"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31502122"],"award-info":[{"award-number":["31502122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Scientific and Technological Projects of Qingdao","award":["16-5-1-49-jch"],"award-info":[{"award-number":["16-5-1-49-jch"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0209177","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T18:33:18Z","timestamp":1546281198000},"page":"e0209177","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacokinetic\/pharmacodynamic (PK\/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model"],"prefix":"10.1371","volume":"13","author":[{"given":"Yongda","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-4447","authenticated-orcid":true,"given":"Binghu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baotao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"issue":"9","key":"ref1","first-page":"306","article-title":"[Tulathromycin, a new antibiotic for farm animals]","volume":"129","author":"M. Morselt","year":"2004","journal-title":"Tijdschr Diergeneeskd"},{"issue":"5","key":"ref2","first-page":"A1","article-title":"Tulathromycin: Overview of a new triamilide antimicrobial for the treatment of respiratory diseases in cows and pigs","volume":"61","author":"NA Evans","year":"2006","journal-title":"Tieraerztl Umschau"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1128\/CVI.00168-13","article-title":"Virulence, Transmission, and Heterologous Protection of Four Isolates of Haemophilus parasuis","volume":"20","author":"SL Brockmeier","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"e103787","DOI":"10.1371\/journal.pone.0103787","article-title":"Virulence and draft genome sequence overview of multiple strains of the swine pathogen Haemophilus parasuis","volume":"9","author":"SL Brockmeier","year":"2014","journal-title":"Plos One"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5465678","DOI":"10.1155\/2016\/5465678","article-title":"Application of PK\/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction","volume":"2016","author":"I Ahmad","year":"2016","journal-title":"Biomed Res Int"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0034-5288(02)00039-5","article-title":"The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics","volume":"73","author":"PL Toutain","year":"2002","journal-title":"Research in Veterinary Science"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1090-0233(02)00271-X","article-title":"Antibiotic treatment of animals\u2014A different approach to rational dosing","volume":"165","author":"PL Toutain","year":"2003","journal-title":"Veterinary Journal"},{"key":"ref8","first-page":"23","article-title":"Antibiotic dosage regimen for a sustainable use of antibiotics in veterinary medicine","volume":"35","author":"PL Toutain","year":"2012","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"RP Dellinger","year":"2008","journal-title":"Crit Care Med"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"JS Solomkin","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"ref11","first-page":"158","article-title":"Pharmacokinetic-pharmacodynamic modelling of antibiotic therapy in severe sepsis","volume":"44","author":"W. Duszynska","year":"2012","journal-title":"Anaesthesiol Intensive Ther"},{"key":"ref12","unstructured":"FDA. 2003. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm072109.pdf\" xlink:type=\"simple\">http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm072109.pdf<\/ext-link>."},{"key":"ref13","unstructured":"FDA. Freedom Information Summary. Original New Animal Drug Application. Draxxin Injectable Solution (Tulathromycin). NADA41\u2013244. 2005. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/cpharm.vetmed.vt.edu\/VM8784\/introduction\/PackageInsert\/draxxin_foi_original.pdf\" xlink:type=\"simple\">http:\/\/cpharm.vetmed.vt.edu\/VM8784\/introduction\/PackageInsert\/draxxin_foi_original.pdf<\/ext-link>."},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cll.2004.03.009","article-title":"Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections","volume":"24","author":"D Andes","year":"2004","journal-title":"Clin Lab Med"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S2095-3119(12)60032-X","article-title":"Development of High Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Detection of Tulathromycin in Swine Plasma","volume":"11","author":"XH Huang","year":"2012","journal-title":"J Integr Agr"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1080\/19440049.2015.1078915","article-title":"Pharmacokinetics of tulathromycin in edible tissues of healthy and experimentally infected pigs with Actinobacillus pleuropneumoniae","volume":"32","author":"T Bladek","year":"2015","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/JCM.01403-16","article-title":"Towards a Standardized Method for Broth Microdilution Susceptibility Testing of Haemophilus parasuis","volume":"55","author":"S Pruller","year":"2017","journal-title":"J Clin Microbiol"},{"year":"2013","key":"ref18","article-title":"CLSI document VET01-A4"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.43.7.1756","article-title":"Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus","volume":"43","author":"Y Dong","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ref20","first-page":"865","article-title":"The postantibiotic effect","volume":"11","author":"JM Spivey","year":"1992","journal-title":"Clin Pharm"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jac\/dkm360","article-title":"AUC\/MIC: a PK\/PD index for antibiotics with a time dimension or simply a dimensionless scoring factor?","volume":"60","author":"PL Toutain","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/infdis\/140.6.881","article-title":"Comparison of antibiotic regimens for treatment of experimental pneumonia due to Pseudomonas","volume":"140","author":"JE Pennington","year":"1979","journal-title":"J Infect Dis"},{"issue":"1","key":"ref23","first-page":"23","article-title":"Experimental infections of mice and guinea pigs with Haemophilus parasuis","volume":"22","author":"T Morozumi","year":"1982","journal-title":"Natl Inst Anim Health Q"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2460\/ajvr.1992.53.05.659","article-title":"Prevalence of Haemophilus parasuis serovars among isolates from swine","volume":"53","author":"VJ Rapp-Gabrielson","year":"1992","journal-title":"Am J Vet Res"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1128\/AAC.00218-12","article-title":"Pharmacokinetics of tulathromycin in healthy and neutropenic mice challenged intranasally with lipopolysaccharide from Escherichia coli","volume":"56","author":"N Villarino","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5455\/vetworld.2012.424-428","article-title":"Pharmacokinetics and bioavailability of tulathromycin following intravenous, intramuscular and subcutaneous administrations in healthy rabbits","volume":"5","author":"K Abo-El-Sooud","year":"2012","journal-title":"Veterinary World"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2885.2004.00586.x","article-title":"Pharmacokinetics and lung tissue concentrations of tulathromycin in swine","volume":"27","author":"HA Benchaoui","year":"2004","journal-title":"J Vet Pharmacol Ther"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1021\/jf0351624","article-title":"An analytical method for the analysis of tulathromycin, an equilibrating triamilide, in bovine and porcine plasma and lung","volume":"52","author":"D Galer","year":"2004","journal-title":"J Agric Food Chem"},{"issue":"1","key":"ref29","first-page":"60","article-title":"Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle","volume":"5","author":"MA Nowakowski","year":"2004","journal-title":"Vet Ther"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tvjl.2006.08.016","article-title":"Evaluation of tulathromycin in the treatment of pulmonary abscesses in foals","volume":"174","author":"M Venner","year":"2007","journal-title":"Vet J"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rvsc.2010.06.025","article-title":"Pharmacokinetics of tulathromycin following subcutaneous administration in meat goats","volume":"90","author":"G Young","year":"2011","journal-title":"Res Vet Sci"},{"issue":"1\u20133","key":"ref32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.smallrumres.2012.07.003","article-title":"Pharmacokinetics of tulathromycin in lactating goats","volume":"108","author":"AMM Amer","year":"2012","journal-title":"Small Ruminant Res"},{"issue":"82","key":"ref33","doi-asserted-by":"crossref","first-page":"0003","DOI":"10.2754\/avb201382010003","article-title":"Antimicrobial susceptibility of Pasteurella multocida and Haemophilus parasuis isolates associated with porcine pneumonia","author":"Ki Nedbalcov\u00e1","year":"2013","journal-title":"ACTA VET"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3389\/fphar.2017.00684","article-title":"Pharmacodynamic Evaluation and PK\/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection","volume":"8","author":"YF Zhou","year":"2017","journal-title":"Front Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3389\/fphar.2017.00392","article-title":"Pharmacokinetic\/Pharmacodynamic Modeling of Tulathromycin against Pasteurella multocida in a Porcine Tissue Cage Model","volume":"8","author":"Q Zhou","year":"2017","journal-title":"Front Pharmacol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jvp.12333","article-title":"Standard PK\/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf","volume":"40","author":"PL Toutain","year":"2017","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"issue":"3\u20134","key":"ref37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.vetmic.2007.11.033","article-title":"Susceptibility testing of tulathromycin: interpretative breakpoints and susceptibility of field isolates","volume":"129","author":"KS Godinho","year":"2008","journal-title":"Vet Microbiol"},{"issue":"2","key":"ref38","first-page":"113","article-title":"Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology","volume":"6","author":"KS Godinho","year":"2005","journal-title":"Vet Ther"},{"issue":"3 Suppl","key":"ref39","first-page":"77S","article-title":"Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era","volume":"57","author":"RC Owens Jr.","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tvjl.2013.07.032","article-title":"The role of the macrolide tulathromycin in veterinary medicine","volume":"198","author":"N Villarino","year":"2013","journal-title":"Veterinary Journal"},{"key":"ref41","article-title":"Time killing kinetics and impact of culture (pH, CO2, and serum) on MIC values of tulathromycin against Haemophilus somnus","author":"C Reese","year":"2004","journal-title":"Proceedings of the 23th World Buiatrics Congress"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/jvp.12134","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations","volume":"37","author":"C Vilalta","year":"2014","journal-title":"J Vet Pharmacol Ther"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/pr.111.005769","article-title":"Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs","volume":"65","author":"E.I. Nielsen","year":"2013","journal-title":"Pharmacological Reviews"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jac\/dkn229","article-title":"A unified anti-mutant dosing strategy","volume":"62","author":"XL Zhao","year":"2008","journal-title":"J Antimicrob Chemoth"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/jac\/dkl135","article-title":"Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration","volume":"57","author":"S.K. Olofsson","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/321841","article-title":"Restricting the Selection of Antibiotic-Resistant Mutants: A General Strategy Derived from Fluoroquinolone Studies","volume":"33","author":"X Zhao","year":"2001","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"ref47","first-page":"1069","article-title":"Dose conversion among different animals and healthy volunteers in pharmacological study","volume":"9","author":"J Huang","year":"2004","journal-title":"Chin J Clin Pharmacol Ther"},{"issue":"7","key":"ref48","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1128\/AAC.00200-15","article-title":"In vivo pharmacokinetic\/pharmacodynamic profiles of valnemulin in an experimental intratracheal Mycoplasma gallisepticum infection model","volume":"59","author":"X Xiao","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0209177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T18:52:56Z","timestamp":1720896776000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0209177"}},"subtitle":[],"editor":[{"given":"Luis Eduardo M.","family":"Quintas","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0209177","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}